Eli Lilly to Deny 340B Drug Pricing Due to Claims-Data Policy: Report

Eli Lilly moves to deny 340B discounts to hospitals refusing to submit claims data under its documentation policy, escalating a months-long standoff with the American Hospital Association and prompting calls for federal intervention.